rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
5	Alcoholic Liver Diseases	C0023896	4	103	5.408442027565741e-09	8e-06	ADH1B,ALDH1A1,CYP2E1,GSTP1
6	Pancreatitis, Alcoholic	C0376670	3	39	1.046841413554489e-08	9.6e-06	ADH1B,CYP2E1,GSTP1
7	Prenatal Exposure Delayed Effects	C0033054	3	52	3.440402074339488e-08	1.12e-05	ADH1B,CYP2E1,GSTP1
11	Oral leukoplakia	C0023532	3	75	1.5299207789531977e-07	1.76e-05	ALDH1A1,CYP2E1,GSTP1
12	DNA Damage	C0012860	3	91	3.34297172277509e-07	1.92e-05	ADH1B,CYP2E1,GSTP1
13	Alcohol abuse	C0085762	3	95	3.975380771237269e-07	2.08e-05	ADH1B,ALDH1A1,CYP2E1
21	Drug Eruptions	C0011609	2	25	5.471733289796887e-07	3.36e-05	CYP2E1,GSTP1
22	Flushing	C0016382	2	25	5.471733289796887e-07	3.52e-05	ADH1B,ALDH1A1
23	Slow acetylator due to N-acetyltransferase enzyme variant	C1827377	2	25	5.471733289796887e-07	3.68e-05	CYP2E1,GSTP1
24	Liver Cirrhosis, Alcoholic	C0023891	3	103	5.50335005122804e-07	3.84e-05	ADH1B,CYP2E1,GSTP1
25	Neoplasm of the rectum	C0034885	3	105	5.945415848529478e-07	4e-05	CYP2E1,GSTP1,PPARD
26	Neoplasm of the larynx	C0023055	3	106	6.176094062837478e-07	4.16e-05	ADH1B,CYP2E1,GSTP1
27	Pleural Neoplasms	C0032229	2	26	6.183334503306881e-07	4.32e-05	ADH1B,CYP2E1
28	Malignant neoplasm of pharynx	C0153405	2	27	6.9532079505219e-07	4.48e-05	CYP2E1,GSTP1
29	Squamous Cell Neoplasms	C0206720	2	29	8.679101606290374e-07	4.64e-05	CYP2E1,GSTP1
30	Rectal Carcinoma	C0149978	4	286	8.917846816558495e-07	4.8e-05	ALDH1A1,CYP2E1,GSTP1,PPARD
34	Liver Diseases	C0023895	5	586	1.3105299294657868e-06	5.44e-05	ADH1B,ALDH1A1,CYP2E1,GSTP1,PPARD
35	Malignant neoplasm of larynx	C0007107	3	133	1.5322611627288651e-06	5.6e-05	ADH1B,CYP2E1,GSTP1
36	Antisocial Personality Disorder	C0003431	2	35	1.5508651808326945e-06	5.76e-05	ADH1B,CYP2E1
37	Genomic Instability	C0919532	2	37	1.8396941990905802e-06	5.92e-05	ADH1B,CYP2E1
38	alcohol use disorder	C0001956	2	38	1.9965398078136687e-06	6.08e-05	ADH1B,CYP2E1
39	Prostate cancer stage C	C0280280	2	39	2.1619821112262017e-06	6.24e-05	ALDH1A1,GSTP1
45	Stomach Diseases	C0038354	2	44	3.126806011666261e-06	7.2e-05	CYP2E1,GSTP1
46	Bone necrosis	C0029445	2	45	3.3487950369393005e-06	7.36e-05	ADH1B,CYP2E1
47	Anxiety Disorders	C0003469	4	383	3.733744048273202e-06	7.52e-05	ADH1B,ALDH1A1,CYP2E1,GSTP1
50	Leukoplakia	C0023531	2	52	5.200778102620873e-06	8e-05	CYP2E1,GSTP1
51	Laryngeal carcinoma	C0595989	3	184	5.570036257229738e-06	8.16e-05	ADH1B,CYP2E1,GSTP1
52	Lip and Oral Cavity Carcinoma	C0220641	4	419	5.783543536419522e-06	8.32e-05	ADH1B,ALDH1A1,CYP2E1,GSTP1
53	Gorlin syndrome	C0004779	2	54	5.832355383983412e-06	8.48e-05	ALDH1A1,GSTP1
54	Cancer of mouth	C0153381	4	420	5.850992002232047e-06	8.64e-05	ADH1B,ALDH1A1,CYP2E1,GSTP1
60	Necrosis	C0027540	2	56	6.512765903354811e-06	9.6e-05	CYP2E1,GSTP1
61	Respiratory Tract Diseases	C0035242	2	56	6.512765903354811e-06	9.76e-05	CYP2E1,GSTP1
62	Cancer of Head and Neck	C0278996	4	430	6.559928289018302e-06	9.92e-05	ADH1B,ALDH1A1,CYP2E1,GSTP1
63	Adenomatous polyp of colon	C0850572	2	61	8.438730497828395e-06	0.0001008	GSTP1,PPARD
68	Childhood Leukemia	C1332977	2	62	8.864177592604605e-06	0.0001088	CYP2E1,GSTP1
69	Neoplasms, Germ Cell and Embryonal	C0027658	2	64	9.75718136220216e-06	0.0001104	ALDH1A1,GSTP1
70	Pharyngeal Neoplasms	C0031347	2	64	9.75718136220216e-06	0.000112	ADH1B,GSTP1
71	Neurodegeneration with brain iron accumulation 4	C4055506	2	66	1.0707776559870652e-05	0.0001136	CYP2E1,GSTP1
75	Occupational Diseases	C0028797	2	68	1.1717562447444152e-05	0.00012	CYP2E1,GSTP1
76	Neoplasm of the oral cavity	C0026640	3	226	1.2542658846981247e-05	0.0001216	ADH1B,CYP2E1,GSTP1
77	Bronchitis	C0006277	2	70	1.2788353955683895e-05	0.0001232	CYP2E1,GSTP1
81	Drug Allergy	C0013182	2	79	1.84072581707051e-05	0.0001296	ADH1B,GSTP1
87	Metaplasia	C0025568	2	80	1.9116717822620366e-05	0.0001392	CYP2E1,GSTP1
88	Chromosome Aberrations	C0008625	2	81	1.984390765585875e-05	0.0001408	CYP2E1,GSTP1
89	Adenoma of large intestine	C1302401	3	257	2.0782855408074674e-05	0.0001424	CYP2E1,GSTP1,PPARD
91	Vestibular Schwannoma	C0027859	2	89	2.6327552959948264e-05	0.0001456	CYP2E1,GSTP1
98	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	C0152025	2	90	2.7224404940628943e-05	0.0001568	ADH1B,GSTP1
99	Pancreatitis	C0030305	3	277	2.7871042523885947e-05	0.0001584	ADH1B,CYP2E1,GSTP1
100	Esophageal carcinoma	C0152018	4	585	2.8979896546710293e-05	0.00016	ADH1B,ALDH1A1,CYP2E1,GSTP1
107	Methamphetamine abuse	C0013146	2	105	4.3178190994974663e-05	0.0001712	ADH1B,GSTP1
108	Carcinoma, Small Cell	C0262584	2	108	4.696680964877409e-05	0.0001728	CYP2E1,GSTP1
109	Non-alcoholic Fatty Liver Disease	C0400966	3	317	4.7174758514789694e-05	0.0001744	CYP2E1,GSTP1,PPARD
110	Malignant tumor of esophagus	C0546837	4	650	4.794334075663986e-05	0.000176	ADH1B,ALDH1A1,CYP2E1,GSTP1
115	Helicobacter Infections	C0079487	2	110	4.9609934871575057e-05	0.000184	CYP2E1,GSTP1
116	Nicotine Dependence	C0028043	2	113	5.375484783975981e-05	0.0001856	ADH1B,CYP2E1
118	Head and Neck Neoplasms	C0018671	3	333	5.7129867456762184e-05	0.0001888	ADH1B,CYP2E1,GSTP1
119	Alcohol dependence	C0001973	4	675	5.7376058063329793e-05	0.0001904	ADH1B,ALDH1A1,CYP2E1,GSTP1
120	Chronic atrophic gastritis	C0017154	2	116	5.812073948419094e-05	0.000192	CYP2E1,GSTP1
121	Gout	C0018099	2	116	5.812073948419094e-05	0.0001936	CYP2E1,PPARD
122	Immediate hypersensitivity	C0020523	2	117	5.96260767711243e-05	0.0001952	ADH1B,GSTP1
123	Esophageal Neoplasms	C0014859	4	686	6.195667938135863e-05	0.0001968	ADH1B,ALDH1A1,CYP2E1,GSTP1
125	Peptic ulcer	C0030920	2	123	6.919738915345253e-05	0.0002	CYP2E1,GSTP1
126	Carcinoma, Endometrioid	C0206687	2	123	6.919738915345253e-05	0.0002016	ALDH1A1,GSTP1
135	Musculoskeletal Diseases	C0026857	2	132	8.535814848786849e-05	0.000216	ADH1B,GSTP1
139	Pregnancy Complications, Hematologic	C0032964	2	133	8.729260003992323e-05	0.0002224	ADH1B,GSTP1
140	 {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against} (3)	C0751688	2	134	8.925553148086962e-05	0.000224	ADH1B,CYP2E1
141	Premature Birth	C0151526	3	376	9.146425283645954e-05	0.0002256	ADH1B,CYP2E1,GSTP1
142	Hereditary pancreatitis	C0238339	3	377	9.240800873500099e-05	0.0002272	ADH1B,CYP2E1,GSTP1
143	Liver Neoplasms, Experimental	C0023904	2	136	9.32675345881595e-05	0.0002288	CYP2E1,GSTP1
144	Motor Neuron Disease	C0085084	2	136	9.32675345881595e-05	0.0002304	CYP2E1,GSTP1
145	Intrauterine growth retardation	C0015934	3	379	9.431686054395261e-05	0.000232	ADH1B,CYP2E1,GSTP1
150	Peripheral neuropathy, myopathy, hoarseness, and hearing loss	C0031117	4	756	9.815096869958406e-05	0.00024	ALDH1A1,CYP2E1,GSTP1,PPARD
151	Adrenoleukodystrophy	C0162309	2	139	9.950379035705836e-05	0.0002416	CYP2E1,GSTP1
154	Chronic liver disease	C0341439	2	144	0.00011049247400019002	0.0002464	ADH1B,CYP2E1
156	Neoplasm of the liver	C0023903	5	1290	0.00011693473037577284	0.0002496	ADH1B,ALDH1A1,CYP2E1,GSTP1,PPARD
157	Asbestosis	C0003949	1	25	0.00012286033869146618	0.0002512	GSTP1
158	Hypercapnia	C0020440	1	25	0.00012286033869146618	0.0002528	GSTP1
159	High altitude pulmonary edema	C0340100	1	25	0.00012286033869146618	0.0002544	GSTP1
160	Latent Tuberculosis	C1609538	1	25	0.00012286033869146618	0.000256	CYP2E1
161	Fibromyxosarcoma	C3714524	1	25	0.00012286033869146618	0.0002576	ALDH1A1
162	Hearing Loss, Partial	C0018772	2	150	0.00012468940466847656	0.0002592	ADH1B,GSTP1
163	Fetal Diseases	C0015929	2	151	0.0001271653921365301	0.0002608	ADH1B,GSTP1
164	Acute-Phase Reaction	C0001349	1	26	0.00013304721146412124	0.0002624	PPARD
165	Neoplasms, Multiple Primary	C0027663	1	26	0.00013304721146412124	0.000264	CYP2E1
166	Pseudomonas Infections	C0033817	1	26	0.00013304721146412124	0.0002656	GSTP1
167	Signs and Symptoms, Respiratory	C0037090	1	26	0.00013304721146412124	0.0002672	GSTP1
168	Sarcoma, Epithelioid	C0205944	1	26	0.00013304721146412124	0.0002688	ALDH1A1
169	Asthma, Occupational	C0264423	1	26	0.00013304721146412124	0.0002704	GSTP1
170	Malignant neoplasm of brain and nervous system	C0153633	2	157	0.00014269705277480949	0.000272	CYP2E1,GSTP1
171	Fetal Alcohol Syndrome	C0015923	1	27	0.00014363533876282641	0.0002736	ADH1B
172	Squamous cell carcinoma of the head and neck	C1168401	4	825	0.0001480525387023146	0.0002752	ADH1B,ALDH1A1,CYP2E1,GSTP1
173	Hepatic steatosis	C0015695	3	427	0.00014933334948552535	0.0002768	CYP2E1,GSTP1,PPARD
174	Chromosomal translocation	C0040715	1	29	0.00016601368713486941	0.0002784	GSTP1
175	Proliferative retinopathy	C0339467	1	29	0.00016601368713486941	0.00028	ADH1B
176	Oculodentodigital dysplasia	C0812437	1	29	0.00016601368713486941	0.0002816	ALDH1A1
177	Systemic arterial pressure	C1272641	3	442	0.00017050108673954956	0.0002832	ADH1B,CYP2E1,GSTP1
178	Neoplasm Invasiveness	C0027626	2	168	0.00017428412790942982	0.0002848	CYP2E1,GSTP1
179	Cholestatic liver disease	C0860204	1	30	0.00017780296584979371	0.0002864	CYP2E1
180	Gastric Mucosa-Associated Lymphoid Tissue Lymphoma	C1333782	1	30	0.00017780296584979371	0.000288	GSTP1
181	Uterine Cervical Neoplasms	C0007873	2	171	0.00018362330990329134	0.0002896	CYP2E1,GSTP1
182	Substance-Related Disorders	C0236969	2	171	0.00018362330990329134	0.0002912	CYP2E1,GSTP1
183	Substance Use Disorders	C0038586	1	31	0.0001899916661266543	0.0002928	ALDH1A1
184	Alcohol withdrawal syndrome	C0236663	1	31	0.0001899916661266543	0.0002944	ADH1B
185	Malaria, Vivax	C0024537	1	32	0.00020257931737521773	0.000296	GSTP1
186	Respiratory Hypersensitivity	C0035228	1	32	0.00020257931737521773	0.0002976	GSTP1
187	Xeroderma Pigmentosum, Complementation Group D	C0268138	1	32	0.00020257931737521773	0.0002992	GSTP1
188	Urinary Bladder Neoplasms	C0005695	3	463	0.00020368929287328807	0.0003008	CYP2E1,GSTP1,PPARD
189	Trisomy	C0041107	2	179	0.00021010435173518527	0.0003024	CYP2E1,GSTP1
190	Medulloblastoma, Childhood	C0278510	1	33	0.00021556544758916107	0.000304	GSTP1
191	Enzyme inhibition disorder	C0877008	1	33	0.00021556544758916107	0.0003056	ADH1B
192	 {Nicotine dependence, protection against}, 188890 (3)	C0439857	1	34	0.00022894970137998794	0.0003072	ADH1B
193	Adenoviral infections	C0851887	1	34	0.00022894970137998794	0.0003088	CYP2E1
194	Germinoma	C0854912	1	34	0.00022894970137998794	0.0003104	GSTP1
195	Erythrocytosis	C1527405	1	34	0.00022894970137998794	0.000312	CYP2E1
196	Hypersensitivity	C0020517	2	186	0.00023521217559530072	0.0003136	ADH1B,GSTP1
197	Dermatosis NOS	C0037274	3	483	0.00023942942391774746	0.0003152	ADH1B,GSTP1,PPARD
198	Lupus Erythematosus, Cutaneous	C0024137	1	35	0.0002427314379170875	0.0003168	GSTP1
199	Rhinitis, Allergic, Perennial	C0035457	1	35	0.0002427314379170875	0.0003184	GSTP1
200	heavy drinking	C0687132	1	35	0.0002427314379170875	0.00032	ADH1B
201	Myelosuppression	C0854467	1	35	0.0002427314379170875	0.0003216	GSTP1
202	Liver Cirrhosis, Biliary	C0023890	4	919	0.0002451323424890184	0.0003232	ADH1B,ALDH1A1,CYP2E1,GSTP1
203	Fibrosis	C0016059	2	191	0.00025428826832085694	0.0003248	CYP2E1,GSTP1
204	Squamous cell carcinoma of lung	C0149782	2	192	0.0002582199454582712	0.0003264	CYP2E1,GSTP1
205	AIDS related complex	C0001857	1	37	0.00027148579256641714	0.000328	GSTP1
206	Connective Tissue Diseases	C0009782	2	196	0.0002743406992302688	0.0003296	ADH1B,GSTP1
207	Drug-Induced Liver Injury	C0860207	2	198	0.0002826398864483881	0.0003312	CYP2E1,GSTP1
208	Simple pneumoconiosis	C0032273	1	38	0.0002864573864721498	0.0003328	GSTP1
209	End Stage Liver Disease	C0745744	1	38	0.0002864573864721498	0.0003344	CYP2E1
210	Pregnancy associated hypertension	C0852036	1	38	0.0002864573864721498	0.000336	GSTP1
211	Gastro-esophageal reflux disease with esophagitis	C0677659	1	39	0.000301824643698545	0.0003376	GSTP1
212	Exfoliation Syndrome	C0206368	1	40	0.0003175872080017905	0.0003392	GSTP1
213	Neurotoxicity Syndromes	C0235032	1	40	0.0003175872080017905	0.0003408	GSTP1
214	Alcoholic Steatohepatitis	C2718067	1	40	0.0003175872080017905	0.0003424	CYP2E1
215	Bronchogenic Carcinoma	C0007121	1	41	0.00033374453022572137	0.000344	GSTP1
216	Allergic sensitization	C3662483	1	41	0.00033374453022572137	0.0003456	GSTP1
